Keywords: pg-txl, enter, trials, radiosensitizer, polymer-bound, formulation, paclitaxel

PG-TXL to enter trials as radiosensitizer

Article | 20 April 1999

Print This

A polymer-bound formulation of paclitaxel, developed at the MD AndersonCancer Center in the USA, may be an effective radiosensitizing agent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in